CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Pharmaceutical Product Development, LLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Pharmaceutical Product Development, LLC
929 North Front Street
Phone: 910 251 0081p:910 251 0081 Wilmington, NC  28401  United States Ticker: PPDIPPDI

This company ceased filing statements with the SEC on 12/15/2011.
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Pharmaceutical Product Development, LLC, operates as a global contract research organization providing drug discovery, development and lifecycle management services. The Company’s clients and partners include pharmaceutical, biotechnology, medical device, academic, non-profit and government organizations. Its development services include preclinical drug discovery services, programs, Phase I through Phase IV clinical development services and post-approval services, as well as bioanalytical, good manufacturing practices (cGMP), global central laboratory and vaccines and biologics laboratory services. It also offers support, such as medical information, patient compliance programs, patient and disease registry programs, product safety and pharmacovigilance, standard response document development, observational studies, Phase IV monitored studies and prescription-to-over-the-counter (Rx to OTC), programs.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/201112/31/2010Yes---Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board Fredric N.Eshelman 62 7/1/2009 7/1/1990
Chief Executive Officer, Director Raymond H.Hill 48 9/16/2011 9/16/2011
Chief Financial Officer, Treasurer, Assistant Secretary Daniel G.Darazsdi 50 10/1/2007 10/1/2007
10 additional Officers and Directors records available in full report.

Business Names
Business Name
0972792 B.C. LTD
AbC.R.O., Inc.
Access to Patients, LLC
135 additional Business Names available in full report.

General Information
Number of Employees: 11,000 (As of 12/31/2010)
Outstanding Shares: 113,685,115 (As of 10/26/2011)
Shareholders: 58,100
Stock Exchange: NASD
Federal Tax Id: 561640186
Fax Number: 910 762 5820
Email Address: info@wilm.ppdi.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023